Page last updated: 2024-09-05

sorafenib and entecavir

sorafenib has been researched along with entecavir in 4 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(entecavir)
Trials
(entecavir)
Recent Studies (post-2010) (entecavir)
6,5207305,2511,8602481,424

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, W; Gu, X; Guan, M; Huang, X; Li, X; Qiu, J; Zhang, Y; Zhao, Y; Zhou, Q; Zou, Y1
D'Angelo, S; De Cristofano, R; Secondulfo, M; Sorrentino, P1
Hu, YQ; Meyer, S; Moyo, H; Tomlinson, C; Waterhouse, C1

Reviews

1 review(s) available for sorafenib and entecavir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for sorafenib and entecavir

ArticleYear
Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.
    European journal of medicinal chemistry, 2020, Nov-01, Volume: 205

    Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Viral; Hepatitis B virus; Humans; Liver Neoplasms; Quinazolinones; Virus Replication

2020
Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma?
    World journal of gastroenterology, 2013, Volume: 19, Issue:14

    Topics: Aged; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Time Factors; Treatment Outcome

2013
How patent law reform can improve affordability and accessibility of medicines in South Africa: Four medicine case studies.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2019, May-31, Volume: 109, Issue:6

    Topics: Antineoplastic Agents; Antiviral Agents; Costs and Cost Analysis; Drug Costs; Drug Industry; Erlotinib Hydrochloride; Guanine; Health Services Accessibility; Humans; Immunologic Factors; Lenalidomide; Patents as Topic; Pharmaceutical Preparations; Sorafenib; South Africa

2019